Comparison of the immunogenicity of five COVID‐19 vaccines in Sri Lanka

To determine the antibody responses elicited by different vaccines against SARS‐CoV‐2, we compared antibody responses in individuals 3 months post‐vaccination in those who had received different vaccines in Sri Lanka. Abs to the receptor binding domain (RBD) of the ancestral (wild type) virus (WT) a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Immunology 2022-10, Vol.167 (2), p.263-274
Hauptverfasser: Jeewandara, Chandima, Aberathna, Inoka Sepali, Danasekara, Saubhagya, Gomes, Laksiri, Fernando, Suranga, Guruge, Dinuka, Ranasinghe, Thushali, Gunasekera, Banuri, Kamaladasa, Achala, Kuruppu, Heshan, Somathilake, Gayasha, Jayamali, Jeewantha, Jayathilaka, Deshni, Wijayatilake, Helanka Dinesh Kumara, Pushpakumara, Pradeep Darshana, Harvie, Michael, Nimasha, Thashmi, Silva, Shiromi Devika Grace, Wijayamuni, Ruwan, Schimanski, Lisa, Rijal, Pramila, Tan, Jack, Townsend, Alain, Ogg, Graham S., Malavige, Gathsaurie Neelika
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To determine the antibody responses elicited by different vaccines against SARS‐CoV‐2, we compared antibody responses in individuals 3 months post‐vaccination in those who had received different vaccines in Sri Lanka. Abs to the receptor binding domain (RBD) of the ancestral (wild type) virus (WT) as well as to variants of concern (VoCs), and ACE2 blocking Abs, were assessed in individuals vaccinated with Moderna (n = 225), Sputnik V (n = 128) or Sputnik light (n = 184) and the results were compared with previously reported data on Sinopharm and AZD1222 vaccinees. A total of 99.5% of Moderna, >94% of AZD1222 or Sputnik V and >70% of Sputnik light, >60% of Sinopharm vaccine recipients, had a positive response to ACE2 blocking antibodies. The ACE2 blocking antibody levels were highest to lowest was Moderna > Sputnik V/AZD1222 (had equal levels) > Sputnik light > Sinopharm. All Moderna recipients had antibodies to the RBD of WT, alpha and beta, while positivity rates for delta variant was 80%. The positivity rates for Sputnik V vaccinees for the WT and VoCs were higher than for AZD1222 vaccinees while those who received Sinopharm had the lowest positivity rates (
ISSN:0019-2805
1365-2567
DOI:10.1111/imm.13535